The latest lymphoma news
Some lymphomas become resistant to treatment; Gene discovery may offer path to overcome it
Patients with some types of lymphoma that become resistant to standard treatments may benefit from…
The latest lymphoma news
Patients with some types of lymphoma that become resistant to standard treatments may benefit from…
Medical image analysis using AI has developed rapidly in recent years. Now, one of the…
On March 7, 2024, the Food and Drug Administration granted accelerated approval to zanubrutinib with…
Chimeric antigen receptor T-cell therapy, or CAR T, has dramatically improved the treatment of certain…
Researchers at The University of Texas at El Paso, USA, have identified a novel pharmaceutical…
The bacteria Staphylococcus aureus (S. aureus) can worsen the condition of patients with the lymphoma type Sezáry…
A Stanford Medicine-led, international study of hundreds of samples from patients with Hodgkin lymphoma has…
The targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival (PFS) and achieved an overall…
CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL),…
A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami…